Anthony R Mato
11PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Mar 14, 2025
Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic Leukemia.Yanping Yin, Haifeng Xu, Liye He
|May 16, 2023
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.Michael L Wang, Wojciech Jurczak, Pier Luigi Zinzani
|Sep 20, 2022
Approach to a patient with "double refractory" chronic lymphocytic leukemia: "Double, double toil and trouble" (Shakespeare).Julia H Aronson, Sigrid S Skånland, Lindsey E Roeker
|Sep 14, 2022
MAJIC: a phase III trial of acalabrutinib + venetoclax versus venetoclax + obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma.Christine E Ryan, Matthew S Davids, Richard Hermann
|Aug 23, 2022
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia.Yanping Yin, Paschalis Athanasiadis, Linda Karlsen
|Jul 26, 2021
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.John C Byrd, Peter Hillmen, Paolo Ghia
Pageof 2
Frequent Collaborators
3 joint publications
Nirav N Shah
2 joint publications
Yanping Yin
2 joint publications
Jennifer R Brown
2 joint publications
Jeffrey J Pu
2 joint publications
Sigrid S Skånland
2 joint publications
Tero Aittokallio
2 joint publications
Haifeng Xu
2 joint publications
John F Seymour
2 joint publications
Frederick Lansigan
1 joint publications
Liye He
